Switching the targeting pathways of a therapeutic antibody by nanodesign.
Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl. 2012 Feb 13; 51(7):1563-7.
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Humanized
-
Cell Line, Tumor
-
Cell Line, Tumor
-
Cetuximab
-
Cetuximab
-
Drug Design
-
Drug Design
-
Gold
-
Gold
-
Humans
-
Humans
-
Metal Nanoparticles
-
Metal Nanoparticles
-
Models, Biological
-
Models, Biological
-
Nanoconjugates
-
Nanoconjugates